Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction

Adam K McDiarmid,Peter P Swoboda,Bara Erhayiem,Katrina Bounford,Petra Bijsterveld,Keith Tyndall,Graham J. Fent,Pankaj Garg,Laura E Dobson,Tarique A Musa,James R. J. Foley,Klaus K. Witte,Mark T. Kearney,John P. Greenwood,Sven Plein

Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction

2020

Adam K McDiarmid
Peter P Swoboda
Bara Erhayiem
Katrina Bounford
Petra Bijsterveld
Keith Tyndall
Graham J. Fent
Pankaj Garg
Laura E Dobson
Tarique A Musa
James R. J. Foley
Klaus K. Witte
Mark T. Kearney
John P. Greenwood
Sven Plein

Background Spironolactone may have prognostic benefit in selected patients with heart failure with preserved ejection fraction. This study assessed the myocardial tissue effects of spironolactone i...

Keywords:

Medicine
Antagonism
Heart failure
Aldosterone
Extracellular fluid
Heart failure with preserved ejection fraction
Spironolactone
Internal medicine
Cardiology
Diabetes mellitus
myocardial tissue

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations